menu Search
Itorvaz

Itorvaz

atorvastatin

Manufacturer:

ACME

Distributor:

Bell-Kenz Pharma

Marketer:

Euro Generics
Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing
Concise Prescribing Info
Contents
Atorvastatin Ca
Indications/Uses
Adjunct to diet for reduction of elevated total cholesterol, LDL-C, Apo B & triglycerides in adults & childn ≥10 yr w/ primary hypercholesterolaemia, heterozygous familial hypercholesterolaemia or combined (mixed) hyperlipidaemia. Raises HDL-C & lowers LDL/HDL & total cholesterol/HDL ratios. Adjunct to diet & non-dietary measures in reducing elevated total cholesterol, LDL-C, & Apo B in patients w/ HoFH. Primary prevention in Type II DM; reducing risk of CV events in diabetic patients w/ at least 1 additional risk factor, w/o clinically evident CHD irrespective of whether cholesterol is raised.
Click to view Itorvaz detailed prescribing information
Dosage/Direction for Use
Adult Primary hypercholesterolaemia & combined hyperlipidaemia 10 mg once daily. Familial hypercholesterolaemia Initially 10 mg daily, increased at intervals of 4 wk to 40 mg once daily. Max: 80 mg once daily. Childn & adolescent 10-17 yr Heterozygous familial hypercholesterolaemia Initially 10 mg once daily. Max: 20 mg daily.
Click to view Itorvaz detailed prescribing information
Overdosage
View Itorvaz overdosage for action to be taken in the event of an overdose.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity. Active liver disease or unexplained persistent elevations of serum transaminases. Pregnancy & lactation.
Click to view Itorvaz detailed prescribing information
Special Precautions
Control hypercholesterolemia w/ appropriate diet, exercise & wt reduction in obese patients & treat other underlying medical problems before instituting therapy. Advise patient to promptly report unexplained muscle pain, tenderness or weakness, particularly if accompanied by malaise or fever. Use adequate contraceptive measures in women of childbearing potential.
Click to view Itorvaz detailed prescribing information
Use In Pregnancy & Lactation
Click to view Itorvaz detailed prescribing information
Drug Interactions
Increased risk of myopathy w/ cyclosporin, fibric acid derivatives, niacin, erythromycin & azole antifungals. Decreased plasma conc w/ antacids containing Mg & Al hydroxide, colestipol. Increased steady-state plasma digoxin conc. Higher plasma conc w/ erythromycin & clarithromycin. Increased AUC values of norethisterone & ethinyl estradiol.
Click to view Itorvaz detailed prescribing information
Caution For Usage
For caution against possible variation of physical aspect of medicine... Click to view Itorvaz detailed prescribing information
Storage
View Itorvaz storage conditions for details to ensure optimal shelf-life.
Description
View Itorvaz description for details of the chemical structure and excipients (inactive components).
Action
View Itorvaz mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class
Dyslipidaemic Agents
ATC Classification
C10AA05 - atorvastatin ; Belongs to the class of HMG CoA reductase inhibitors. Used in the treatment of hyperlipidemia.
Regulatory Classification
Rx
Presentation/Packing
Form
Itorvaz FC tab 20 mg
Packing/Price
30's (P450/box, P15/film-coated tab)
Form
Itorvaz FC tab 40 mg
Packing/Price
30's (P21.5/film-coated tab, P645/box)
Form
Itorvaz FC tab 80 mg
Packing/Price
30's (P26.5/film-coated tab, P795/box)